Rockefeller Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-21
| Closed | -$3K | – | 4456 |
|
|
2022
Q3 | $3K | Sell |
21
-26
| -55% | -$3.71K | ﹤0.01% | 3541 |
|
|
2022
Q2 | $6K | Sell |
47
-8
| -15% | -$1.02K | ﹤0.01% | 3413 |
|
|
2022
Q1 | $6K | Sell |
55
-94
| -63% | -$10.3K | ﹤0.01% | 3310 |
|
|
2021
Q4 | $20K | Buy |
+149
| New | +$20K | ﹤0.01% | 2660 |
|
|
2021
Q3 | – | Sell |
-13
| Closed | -$1K | – | 3994 |
|
|
2021
Q2 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 3415 |
|
|
2021
Q1 | – | Sell |
-1,413
| Closed | -$121K | – | 3493 |
|
|
2020
Q4 | $121K | Sell |
1,413
-2,096
| -60% | -$179K | ﹤0.01% | 1369 |
|
|
2020
Q3 | $228K | Buy |
3,509
+757
| +28% | +$49.2K | ﹤0.01% | 998 |
|
|
2020
Q2 | $201K | Sell |
2,752
-2,232
| -45% | -$163K | ﹤0.01% | 950 |
|
|
2020
Q1 | $170K | Hold |
4,984
| – | – | ﹤0.01% | 860 |
|
|
2019
Q4 | $271K | Buy |
+4,984
| New | +$271K | ﹤0.01% | 701 |
|